Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - April 2013


2nd Digital Marketing for Medical Devices West

29 Apr 2013 - 01 May 2013 - San Diego, CA, USA



Bookmark and Share


Digital marketing has opened the door to opportunities never before believed possible. Based on the success of ExL’s inaugural 2012 west conference and the previous two Minneapolis conferences, we aim to further expand the industry’s leading device-specific digital marketing conference. 

Being the industry’s ONLY conference of its kind, this will allow you to dive into the many issues and emerging opportunities for digital marketing facing medical device professionals today. Participants have an opportunity to network, share ideas and explore digital marketing success stores and innovations. From mobile to social, you will learn cutting-edge trends and ideas as well as novel strategies needed for practical application.

Join 150+ experienced medical device-marketing executives in late April 2013 to share ideas and explore digital marketing success stores and innovations. From mobile to social, you will learn cutting-edge trends and ideas as well as novel strategies needed for practical application.

Key Program Sessions Include:

Leveraging global market access using digital technology

Branded content: Make it good, or don’t make it at all

Creating a comprehensive digital marketing strategy to fit the needs of your product

How to navigate social media in a regulated environment

Mobile marketing: Best practices for cracking today’s most intimate channel

Effectively combining multiple marketing strategies in a digital format

Transforming the customer experience through interactive media

Creating a interconnected multi-channel digital marketing campaign to aid sales force efforts

Advanced search marketing: Can local, social, SEM and SEO all work together?

Expanding customer website traffic through leveraging novel mobile marketing strategies

Enhancing strategy through novel cloud and customer-facing technologies

Influencing discussion: The role of patient social networks in device marketing 



Further information
Scientific News
Liquid Biopsies: Utilization of Circulating Biomarkers for Minimally Invasive Diagnostics Development
Market Trends in Biofluid-based Liquid Biopsies: Deploying Circulating Biomarkers in the Clinic. Enal Razvi, Ph.D., Managing Director, Select Biosciences, Inc.
Study Questions Presence in Blood of Heart-Healthy Molecules from Fish Oil Supplements
A new study from the Perelman School of Medicine at the University of Pennsylvania questions the relevance of fish oil-derived SPMs and their purported anti-inflammatory effects in humans.
Experimental MERS Vaccine Shows Promise in Animal Studies
A two-step regimen of experimental vaccines against Middle East respiratory syndrome (MERS) prompted immune responses in mice and rhesus macaques, report National Institutes of Health scientists who designed the vaccines.
Young South African Women can Adhere to Daily PrEP Regimen as HIV Prevention
NIH-funded study finds men in Bangkok, Harlem also successful in taking daily dose.
Key Player in Diabetic Kidney Disease Revealed
Discovery could lead to new and better diagnostic marker for chronic kidney disease.
Immunotherapy Shows Promise for Myeloma
A strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Santhera Announces First Patient Dosing with Omigapil in CMD
Company announces full patient recruitment of CALLISTO study.
Study Shows Promise of Precision Medicine for Most Common Type of Lymphoma
The study appeared online July 20, 2015, in Nature Medicine.
HIV Control Through Treatment Durably Prevents Heterosexual Transmission of Virus
NIH-funded trial proves suppressive antiretroviral therapy for HIV-infected people effective in protecting uninfected partners.
Adaptimmune's Novel Cancer Therapeutics Show Positive Clinical Trial Results
The company has announced that positive data from its Phase I/II study of its affinity enhanced T-cell receptor (TCR) therapeutic targeting the NY-ESO-1 cancer antigen in patients with multiple myeloma has been published.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!